Participating Faculty

Supplements and Featured Publications, Clinical Update on Oncology Treatments and Trends, Volume 12, Issue 3 suppl

The American Journal of Managed Care

This supplement to provides participants with a clinicalupdate on treatments for lung, colorectal, and breast cancers, and lymphoproliferative disorders.Kenneth W. Lane, a freelance medical writer and editor, contributed to the writing of this supplement.This supplement has been reviewed by an expert in the field.

Guest Editor

B. Jay Brooks, Jr, MD

Chief, Department of Hematology and Oncology

Ochsner Clinic Foundation

Baton Rouge, Louisiana

Faculty Disclosure

In accordance with the ACCME, participants for this activity have completed conflict-of-intereststatements.

In compliance with the Health Insurance Portability and Accountability Act standards, no presentationsin this CME activity shall disclose the names or other identifiers of patients referencedwithout a signed waiver from the identified patient.

The American Journal of Managed Care

It is the policy of to have all faculty who participatein programs sponsored by pharmaceutical companies disclose any real or apparent conflict ofinterest.

Dr. Brooks reports serving on an advisory panel and the National Steering Committee forOncology for Genentech.

Investigational and/or Off-label Use of Commercial Products and Devices

The University of Cincinnati College of Medicine requires all faculty to disclose any discussion ofinvestigational and/or off-label use of a pharmaceutical product or device within their presentation/report. Participants should note that the use of products outside US Food and DrugAdministration-approved labeling should be considered experimental and are advised to consultcurrent prescribing information for approved indications.

Dr. Brooks does not discuss any investigational and/or off-label use of a pharmaceutical productor device.

The American Journal of Managed Care

A signed disclosure is on file at the offices of , Jamesburg,New Jersey.